Oncology Unscripted With John Marshall: Episode 27: Groundhog Day, The Ice Palace, and $25 Trillion Cancer Costs

Oncology Unscripted With John Marshall: Episode 31: ASCO 2026 Preview: Precision Medicine, MRD, and the Next Wave of Care

MedBuzz: In this episode of Oncology Unscripted, John Marshall, MD, discusses a troubling week in health care news, including upheaval at the FDA, concerns about reduced federal support for medical education, and growing evidence that AI-generated fabricated references are appearing in published scientific literature. Main Topic: In this episode of Oncology Unscripted, Dr John Marshall previews the practice-changing data expected at ASCO 2026, highlighting advances in precision medicine. Tune in to hear which presentations could shape the next wave of cancer care. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com [https://pcm.adswizz.com] for information about our collection and use of personal data for advertising.

Oncology Unscripted With John Marshall: Episode 30: Navigating the Expanding Role of Precision Medicine

MedBuzz: In this episode of Oncology Unscripted MedBuzz, Dr Marshall discusses evolving rectal cancer data and the growing role of genomic testing. He also reflects on US science policy and concerns about instability, and the need to modernize clinical trials while protecting independent oversight and patient data. Main Topic: In this episode of Oncology Unscripted, Dr Marshall discusses the growing role of precision medicine in oncology and how it is shifting from an optional tool to a standard part of cancer care, including the increasing importance of MRD and ctDNA, and promise of blood-based cancer screening. Interview: In this episode of Candid Conversations , Dr. John Marshall speaks with Dr. Marija Balic of UPMC and the University of Pittsburgh about MRD ctDNA testing in early breast cancer. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com [https://pcm.adswizz.com] for information about our collection and use of personal data for advertising.

Oncology Unscripted With John Marshall: Episode 29: AI in Cancer Care: Promise, Pressure, and the Physician’s Role

MedBuzz: In this MedBuzz, Dr John Marshall discusses Steve Ubl’s departure from PhRMA and what it may signal for drug pricing, pharmaceutical policy, payer dynamics, and patient access.  Main Topic: In this episode of Oncology Unscripted, Dr John Marshall explores the growing role of AI in cancer care, from analyzing patient data and predicting treatment responses to supporting clinical trials, guidelines, manuscripts, and patient communication. He also reflects on the risks of AI, including privacy, bias, accountability, energy demands, and the potential loss of human connection in medicine. Interview: In this expert panel discussion of Oncology Unscripted, Dr John Marshall explores how artificial intelligence is being used in health care today and where it may be headed next. Guests Neel Trivedi, MD; Ross Filice, MD; and Torbjørn Furuseth, MD, discuss AI scribes, radiology, digital pathology, clinical decision-making, patient privacy, and the ongoing role of human judgment in medicine. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com [https://pcm.adswizz.com] for information about our collection and use of personal data for advertising.

Oncology Unscripted With John Marshall: Episode 28: Are We Watching a Global Evolution in Cancer Care Leadership?

MedBuzz: After a trip to the Galapagos, Dr John Marshall reflects on evolution in nature, cancer, and medicine. From Darwin’s observations to the rise of AI and precision oncology, he explores how rapidly cancer adapts, how technology is reshaping care, and why the future of medicine must still preserve the human touch. Main Topic: In this episode of Oncology Unscripted, Dr John Marshall reflects on a practice-changing cholangiocarcinoma study from China and what it reveals about the rapid evolution of cancer research worldwide. As novel therapies transform care and China expands its investment in science while the US devests, he asks whether we can keep pace and the impacts of the global evolution of in oncology. Interview:   Watch now as Dr John Marshall sits down with Dr Louis Weiner, director of Georgetown University’s Lombardi Cancer Center, for a candid conversation about leadership, scientific change, and the future of oncology. Reflecting on innovation, institutional transition, and the pressures reshaping cancer research, they explore what it means to evolve as a leader and honoring the work and the people. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com [https://pcm.adswizz.com] for information about our collection and use of personal data for advertising.

Oncology Unscripted With John Marshall: Episode 27: Groundhog Day, The Ice Palace, and $25 Trillion Cancer Costs

MedBuzz: Watch now as Dr Marshall discusses the growing instability at the FDA, including job cuts, leadership turnover, and structural reorganization. Main Topic: This episode of Oncology Unscripted explores the projected $25 trillion global cost of cancer care, rising cancer incidence, and declining mortality, all set against political and funding uncertainty in frozen Washington, DC. Interview: In this episode of Oncology Unscripted, John Marshall, MD, sits down with Richard Pazdur, MD, former director of the FDA’s Oncology Center of Excellence, for a candid discussion about his transition to and from the FDA, reflecting on what’s been built and what is at risk of being lost. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.